31/12/2025
DON'T MISS IT
Regulatory Notice: Applications described here may or may not be approved in your country. Please che
Via Baldanzese, 17
Calenzano
50041
Lasciando la tua email puoi essere il primo a sapere quando Elesta - Beyond Laser pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.
Invia un messaggio a Elesta - Beyond Laser:
We develop innovative hi-tech therapeutic applications for interventional medicine. Our main product is EchoLaser: the first and unique integrated Laser-Ultrasound system that allows for the diagnosis and micro-invasive treatment of benign and malignant tumours. EchoLaser uses the laser radiation transmitted by independent sources (up to 4) through extremely thin optical fibres (0,3 mm) inserted percutaneously under a proprietary ultrasound guiding system (which includes a planning and simulation software). EchoLaser Therapy can induce a cytoreduction process on benign lesions (e.g.: BPH, thyroid nodules, etc.) or destroy cancerous tissue of malignant lesions (e.g.: metastatic lymph nodes, liver cancer, low-risk localized prostate and kidney cancer, etc.). No general anesthesia is generally required. Procedures can be performed in an outpatient regimen, with consequent faster recovery after treatment.
We want to play an important role in the new frontier of Precision Medicine, which is more than genomics and bespoke pharmacological treatment, but includes more accurate imaging and non surgical treatments (e.g. ablation).
The core EchoLaser Therapy treatments are: